Klivira
Request demo

Accelerating Radiation Oncology Express Scripts Integration for Critical Therapies

Klivira provides a robust solution for radiation oncology Express Scripts integration, automating the complex prior authorization workflow for high-cost radiotherapy regimens and associated medications.

Revenue cycle directors and prior authorization coordinators in radiation oncology face unique challenges with PBM authorizations, particularly for specialized treatments and supportive drugs. Manual processes for Express Scripts PAs can delay critical patient care and strain administrative resources, impacting both financial performance and patient outcomes.

The Nuances of Express Scripts Prior Authorization in Radiation Oncology

Radiation oncology involves highly specialized, often high-cost treatments like IMRT, proton beam therapy, SBRT, and brachytherapy. While Express Scripts primarily manages pharmacy benefits, their prior authorization requirements extend to certain radiopharmaceuticals, supportive oncology drugs, and even specific advanced imaging studies that inform radiotherapy planning, creating a distinct PA burden for rad onc practices.

Common Express Scripts PA Triggers in Radiation Oncology

  • High-cost supportive oncology drugs administered during or post-radiotherapy
  • Specific radiopharmaceuticals used in diagnostic imaging or therapeutic applications
  • Advanced imaging modalities (e.g., PET scans) when covered under pharmacy benefits or requiring PBM review
  • Select oral oncolytics or targeted therapies prescribed in conjunction with radiation
  • Certain antiemetics or pain management medications with high acquisition costs

Optimizing EMR Data Extraction for Express Scripts Submissions

Efficient radiation oncology Express Scripts integration hinges on seamless data extraction from the EMR. Klivira leverages SMART on FHIR capabilities to pull critical patient demographics, diagnosis codes (ICD-10), treatment plans, dosimetry reports, and relevant clinical notes, ensuring comprehensive and accurate submissions via ePA channels.

Aligning with Clinical Guidelines for Expedited Express Scripts Approvals

Express Scripts, like other PBMs, often references established clinical guidelines from bodies such as NCCN, ACR, and ASCO when reviewing prior authorization requests. Klivira's platform helps structure submissions to clearly demonstrate medical necessity and adherence to these evidence-based protocols, facilitating faster approvals for radiation oncology cases.

Streamlining the Express Scripts ePA Workflow for Radiation Oncology

  • Automated identification of PA requirements based on CPT/HCPCS codes and drug NDCs
  • Intelligent extraction of clinical data (e.g., staging, performance status, prior therapies) from EMRs
  • Pre-population of Express Scripts-specific ePA forms via X12 278 or NCPDP SCRIPT
  • Real-time status tracking and automated follow-ups for pending authorizations
  • Integration with payer portals for direct submission and documentation upload

Impact on Patient Care and Revenue Cycle in Radiation Oncology

Delays in Express Scripts prior authorization for radiation oncology treatments or associated medications can significantly impact patient treatment timelines and outcomes. By automating this process, Klivira helps accelerate patient access to critical therapies, reduces administrative burden, and minimizes denial rates, directly improving the revenue cycle and overall operational efficiency for radiation oncology practices.

Frequently asked questions

Which specific radiation oncology-related medications or services frequently require Express Scripts prior authorization?

Express Scripts, as a PBM, typically requires prior authorization for high-cost supportive oncology medications, certain radiopharmaceuticals, and specific oral oncolytics prescribed within a radiation oncology regimen. This also includes some advanced diagnostic imaging procedures if covered under the pharmacy benefit.

How does Klivira integrate with our EMR to gather radiation oncology-specific data for Express Scripts PAs?

Klivira utilizes secure, standards-based EMR integrations, including SMART on FHIR, to extract relevant clinical documentation. For radiation oncology, this includes diagnosis codes, treatment plans, dosimetry details, patient history, and imaging reports, ensuring all necessary data points for an Express Scripts submission are captured accurately.

What clinical documentation is most critical for Express Scripts PAs in radiation oncology?

Critical documentation includes precise diagnosis (ICD-10), details of the proposed radiation therapy (e.g., IMRT, SBRT), patient performance status, prior treatment history, relevant imaging reports, and supporting lab results. Demonstrating alignment with NCCN or ACR guidelines is also highly beneficial.

Can Klivira handle both drug-related and procedure-related PAs for radiation oncology services via Express Scripts?

Klivira primarily streamlines prior authorizations for drug-related services managed by PBMs like Express Scripts. While Express Scripts focuses on pharmacy benefits, our platform ensures efficient processing for all medications and associated services that fall under their PA requirements within the radiation oncology setting.

Does Klivira support specific Express Scripts ePA submission channels?

Yes, Klivira supports multiple electronic prior authorization channels, including direct integrations via X12 278 and NCPDP SCRIPT standards. This ensures that radiation oncology practices can submit Express Scripts PAs efficiently through the most appropriate and compliant digital pathways.

Related coverage

Other radiation-oncology prior auth workflows

Ready to automate this workflow for this specialty?

See how Klivira automates prior authorizations for your team.

Request a demo